Lenvatinib Can Overcome Immune Resistance in Head and Neck Cancer and Achieve Durable Remission
South Asian J Cancer
.
2023 Mar 9;13(3):224-225.
doi: 10.1055/s-0043-1762939.
eCollection 2024 Jul.
Authors
Oshin Suri
1
,
Vineet Govinda Gupta
1
Affiliation
1
Department of Medical Oncology, Artemis Hospital, Gurugram, India.
PMID:
39410981
PMCID:
PMC11473131
DOI:
10.1055/s-0043-1762939
No abstract available